Abstract:Objective:To explore the biocompatibility and transmembrane transport capacity of the new amino-modified magnetic mesoporous silica nanoparticles and observe metabolic profile of the nanoparticles in vivo, in order to evaluate the possibility of these nanoparticles performing in gene or drug carriers prospect. Methods:Prepare the new mesoporous silica nanoparticles and packaging with 20nm iron oxide core, then amino-modified. After finishing producing these nanoparticles, we do several examinations about this MSNs, including cytotoxicity, cell plasmid carrying the N-methyl-D-aspartate (NMDA) receptor NR2B subunit gene small interfering RNA (siRNA) transfection experiments, as well as the mesoporous silica nanoparticles in cell culture in order to study their distribution in cells and mice in vivo. and injection simulation to study the in vivo biological distribution. Results:The new magnetic amino-modified mesoporous silica nanoparticles with a diameter between 80-100nm, aperture size 2-4 nm, uni-ball-shape. Exposing in 5 μg/ml-125 μg/ml concentration range, no significant difference in the activity of cells in the mesoporous silica nanoparticles was found. In the flow cytometry analysis, with the increasing concentration, the apoptosis of cells appear slightly increased, but remain below 6% in total. Curcumin staining loaded with the nanoparticle NR2B siRNA plasmid transfection experiments, the phenomenon can be observed intracellular fluorescence under a fluorescence microscope. In vitro observation of infrared detector infrared excitation fluorescent dye-labeled nanoparticle experiments, showing that the nanoparticles will not accumulate in mice, which will eventually converge with the urine throμgh the kidneys to the bladder, and eventually excreted. While in the case of an applied magnetic field, there will be a large number of fluorescent particles in the magnetic field direction of the gathering, and after the withdrawal of the magnetic field does not accumulate, concentrations continued to decline. Conclusion:Aminated magnetic mesoporous silica particles, because its excellent loading capacity, better biosecurity and transmembrane transport capacity. Therefore we carry out the biological safety trials of MSN, and lay the foundation for the ultimately efficient, safe mesoporous silica vector used for gene therapy of cancer pain.

Preparation and Biological Savety Evaluation of Silicon Nanoparticles for Gene Therapy

Surface Modification and Biomedical Application of Silica Nanoparticles

Regulation the Morphology of Cationized Gold Nanoparticles for Effective Gene Delivery.

Silica Nanoparticles Modified As Carriers for Gene Transfection

Biocompatible Protamine Sulfate@Silicon Nanoparticle-Based Gene Nanocarriers Featuring Strong And Stable Fluorescence

Research of the cytotoxicity and distribution of amino-modified magnetic mesoporous silicate nanoparticles in vitro and in vivo

[Biocompatibility of Poly-L-lysine-modified Silica Nanoparticles].

Fluorescent Silicon Nanoparticle-Based Gene Carriers Featuring Strong Photostability and Feeble Cytotoxicity

Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances.

Poly-L-Lysine-Modified Silica Nanoparticles: A Potential Oral Gene Delivery System

A novel gene carrier based on amino-modified silica nanoparticles

Preparation of Ε-Polylysine Modified Silica Nanoparticles

Promising Plasmid DNA Vector Based on APTES-modified Silica Nanoparticles

Improved Gene Transfer by Functionalized Hollow Mesoporous Silica Nanoparticles with Low Cytotoxicity

In Vivo Bio-distribution and Efficient Tumor Targeting of Gelatin/Silica Nanoparticles for Gene Delivery.

Size-dependent Gene Delivery of Amine-Modified Silica Nanoparticles

[Hydroxyapatite Nanoparticles: a Novel Material of Gene Carrier].

Improved Gene Transfer with Functionalized Hollow Mesoporous Silica Nanoparticles of Reduced Cytotoxicity.

Clinical Evaluations of Toxicity and Efficacy of Nanoparticle-Mediated Gene Therapy

[Biotoxicology and Biodynamics of Silica Nanoparticle].

Sodium Chloride Modified Silica Nanoparticles As a Non-Viral Vector with a High Efficiency of DNA Transfer into Cells.